| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3115641
Max Phase: Preclinical
Molecular Formula: C19H19N3O
Molecular Weight: 305.38
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: NC(C(=O)N1CCc2c([nH]c3ccccc23)C1)c1ccccc1
Standard InChI: InChI=1S/C19H19N3O/c20-18(13-6-2-1-3-7-13)19(23)22-11-10-15-14-8-4-5-9-16(14)21-17(15)12-22/h1-9,18,21H,10-12,20H2
Standard InChI Key: DIVHKPGTGXDMBT-UHFFFAOYSA-N
Associated Targets(Human)
Transforming growth factor beta-1 34 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 305.38 | Molecular Weight (Monoisotopic): 305.1528 | AlogP: 2.75 | #Rotatable Bonds: 2 |
| Polar Surface Area: 62.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.52 | CX LogP: 2.21 | CX LogD: 1.85 |
| Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.76 | Np Likeness Score: -0.42 |
References
| 1. Zheng C, Fang Y, Tong W, Li G, Wu H, Zhou W, Lin Q, Yang F, Yang Z, Wang P, Peng Y, Pang X, Yi Z, Luo J, Liu M, Chen Y.. (2014) Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway., 57 (3): [PMID:24417479] [10.1021/jm401117t] |
Source
Source(1):